Home / Insights / Mylan's Development in India: A Leapfrog Strategy against Global Generic Competition

insights-espresso-icon article

Mylan's Development in India: A Leapfrog Strategy against Global Generic Competition

Espresso-live Speakers
by Pradeep VNK
29 September 2013

Big pharmaceutical companies are eyeing India as their potential hub for procurement; some have even set up their regional sourcing centers and procurement teams to leverage low cost sourcing destinations such as India and China. At the time when most big pharma companies are shutting down their manufacturing facilities and outsourcing their operations, Mylan inc., has expanded largely. Its expansion plans have been perfect so far with row of fine picked facilities and businesses. This article will analyze the expansion of Mylan as a shift from procurement from India to setting up their manufacturing base in India.   Author: Pradeep VNK

SHARE
Linkedin Twitter Facebook
Leave a comment

Please enter a valid name

Post your comment

Please select captcha

Instagram

Get more stories like this

Subscirbe for more news,updates and insights from Beroe